梅花生物：公司正在按照既定的计划对收购的海外业务进行整合

Group 1 - The company is integrating its acquired overseas business according to its established plan, with specific performance details available in regular reports [1] - The acquired assets primarily consist of pharmaceutical amino acid products, including arginine and histidine, for which domestic production bases have initiated project preparations [1]